Tandem Diabetes Care completes acquisition of insulin pump maker AMF Medical

The Sigi insulin patch pump. [Image courtesy of Tandem Diabetes Care/AMF Medical]Tandem Diabetes Care (Nasdaq:TNDM) announced today that it completed its previously announced acquisition of AMF Medical.

San Diego-based Tandem announced plans to acquire the maker of the Sigi patch pump for insulin delivery last month. Switzerland-based AMF Medical does not offer Sigi commercially. The system received FDA breakthrough device designation just over one year ago.

The Sigi system, an ergonomic, rechargeable patch pump, features pre-filled insulin cartridges to reduce the burden of managing diabetes.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Tandem Diabetes Care to acquire patch pump maker AMF Medical

The Sigi insulin patch pump. [Image courtesy of Tandem Diabetes Care/AMF Medical]Tandem Diabetes Care (Nasdaq:TNDM) announced today that it acquired AMF Medical, maker of the Sigi patch pump for insulin delivery.

Switzerland-based AMF Medical currently develops the Sigi patch pump and does not offer it commercially. The system received FDA breakthrough device designation just over one year ago.

AMF Medical designed Sigi as an ergonomic, rechargeable patch pump for reducing the burden of diabetes management. It uses pre-filled insulin cartridges and offers compatibility with automated insulin delivery technology.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

AMF Medical wins breakthrough nod for insulin management system

[Image from AMF Medical]AMF Medical announced today that it received FDA breakthrough device designation for its Sigi insulin management system.

Ecublens, Switzerland-based AMF Medical’s Sigi (for diabetes mellitus treatment) can be programmed to deliver basal and bolus insulin at both set and variable rates.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0